ExciPlex
ExciPlex is a Michigan-based deep-tech company founded in 2020 that develops proprietary exciplex-based photochemical detection technology, purified toxin reference materials, and portable diagnostic instruments for mycotoxin, cyanotoxin, and plant-toxin surveillance in animal feed, food, water, and environmental monitoring applications.
- Company typePrivate
- Founded2020
- HeadquartersAnn Arbor, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What ExciPlex does
ExciPlex, Inc. is a private deep-tech diagnostic company founded in 2020 by Daryl Staveness, Ph.D. (Stanford University, Ph.D. in Organic Chemistry, 2015; postdoctoral fellow at the University of Michigan), with co-founder Chuck Cauchy serving as strategic advisor. Headquartered in Traverse City, Michigan, with laboratory operations at the Grand Valley State University Incubator Hub, the company specializes in the detection of natural toxins—particularly mycotoxins, cyanotoxins, ergot alkaloids, and plant-derived toxins—that are economically important in animal feed, food quality, water treatment, and environmental monitoring.
The company's core technology rests on a proprietary exciplex-based photochemical detection concept that enables molecular-level signal generation across multiple analyte classes. ExciPlex monetizes this capability through three integrated layers: (1) purified toxin reference materials and specialty chemicals sold in standardized 10/25/100 mg unit sizes (with the ergot alkaloid line as flagship) for analytical labs and certified reference material suppliers; (2) proprietary reagent components including extraction buffers, assay buffers, and culture media designed for compatibility with photometric and immunoassay platforms; and (3) a portable dual-mode spectrophotometer/fluorimeter instrument paired with proprietary quantification and cloud-connected smartphone data-tracking software for on-site toxin vigilance.
Revenue is generated through a mix of small-batch specialty chemical product sales, contract assay development and synthetic chemistry services, consulting engagements, hardware sales of the portable detection device, and flexible technology licensing/partnership structures for OEM integration. Customer engagement is sales-led and direct, supported by founder-driven outreach via LinkedIn, the company website, accelerator networks (Hatch, Activate), and industry events/competitions. Primary customer segments include agricultural monitoring (animal nutrition, feed production, food quality), environmental monitoring (water treatment and recreational water), analytical laboratories, and aquaculture operators; named enterprise customers are not disclosed, and pricing is quote-based rather than publicly listed.
ExciPlex firmographics
Firmographics- Name
- ExciPlex
- Legal name
- ExciPlex, Inc.
- Website
- https://exciplexinc.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ExciPlex is a Michigan-based deep-tech company founded in 2020 that develops proprietary exciplex-based photochemical detection technology, purified toxin reference materials, and portable diagnostic instruments for mycotoxin, cyanotoxin, and plant-toxin surveillance in animal feed, food, water, and environmental monitoring applications.
- Ownership category
- akta.pro rank
ExciPlex industry classification
Industry- Product category
- Toxin Detection Diagnostics
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Testing Laboratories and Services (54138)
- SIC
- Services-Testing Laboratories (8734), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Mycotoxin Testing (Aflatoxins, Ochratoxin, DON, ZEN, Fumonisins) (AFALAFAC)
- akta.pro secondary industries
- Residue & Contaminant Testing (Pesticides, Vet Drugs, Mycotoxins, Heavy Metals) (AFALAAAF), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Emerging Contaminants Testing & Risk Management (PFAS, microplastics, pharmaceuticals) (EUANAJAF)
Keywords
Where ExciPlex is headquartered
LocationHeadquarters
- HQ city
- Ann Arbor
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
ExciPlex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Toxin and Specialty Chemical Products: Sale of purified toxins (ergot alkaloids, mycotoxins, cyanotoxins, pyrrolizidine alkaloids) and specialty chemicals in unit sizes of 10mg, 25mg, or 100mg with custom sizes available upon request.
- Assay Development Services: Contract research services including protocol optimization, assay component development, assay validation, and R&D troubleshooting for biotech, agtech, and life sciences companies.
- Synthetic Chemistry Services: Library design and synthesis, conjugation chemistry, reaction optimization, and sequence development for medicinal chemistry, agrochemistry, and translational science applications.
- Consulting Services: R&D troubleshooting, strategic partnership sourcing, intellectual property evaluations, and investor due diligence services for entrepreneurs, corporations, and investors.
- Portable Detection Devices: Sale of dual-mode portable spectrophotometer/fluorimeter devices with proprietary software for field-based toxin detection.
- Technology Licensing and Partnership: Flexible licensing and partnership structures for integration of ExciPlex's proprietary assay components, detection technologies, and data tracking systems into partner products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Purified Toxins - Standard Unit Sizes |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
ExciPlex product offering
Product offeringCore offering
ExciPlex invents diagnostic assays, builds detection systems, and supplies critical reference materials for agricultural and environmental monitoring of natural toxins. The company manufactures high-purity purified toxins (mycotoxins, cyanotoxins, plant-derived toxins, ergot alkaloids), proprietary assay components (extraction buffers, assay buffers, culture media), and a portable dual-mode spectrophotometer/fluorimeter with cloud-connected quantification software. It complements these products with assay development, synthetic chemistry, and consulting services.
Product overview
ExciPlex offers a unified portfolio of toxin detection solutions combining physical products and services. The core product line centers on purified toxins (Ergot Alkaloids as flagship) and specialty chemicals for agricultural and environmental monitoring. Complementary assay components (Extraction Buffers, Assay Buffers, Culture Media) support diagnostic development. The On-Site Diagnostic Solutions platform integrates assay kits with a proprietary Portable Detection Device (dual-mode spectrophotometer and fluorimeter) featuring customizable quantification software and cloud-connected data tracking. Services span assay development, synthetic chemistry, and consulting (R&D troubleshooting, IP evaluation, investor due diligence), creating a comprehensive toxin vigilance offering for laboratories, feed/food producers, water treatment facilities, and environmental monitoring organizations.
Differentiator
Problem solved
Functional benefit
Products and services
- Ergot Alkaloids (Purified Toxin Portfolio)
Companies that use ExciPlex
Customer profileSegments4 records
Ideal customer profiles5 records
ExciPlex technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
ExciPlex partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- Michigan Innovation Headquarters (MI-HQ)minorLocated at MI-HQ in Ann Arbor during 2020-2021, a common launching pad for some of Michigan's most disruptive companies in biotech and beyond.
- David W. Fletcher IncubatorminorLaboratory relocated to the David W. Fletcher Incubator at Hagerstown Community College campus at the beginning of 2022. Newly renovated space designed to help propel early-stage companies into growth-phase.
- 20FathomscoreHeadquarters retained in Traverse City, MI at 20Fathoms, a resource for early-stage tech-centric business in Northern Michigan. 20Fathoms is described as a phenomenal resource for early-stage tech businesses.
- Grand Valley State University Incubator HubminorLaboratory relocated to Grand Valley State Incubator Hub in mid-2024.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
ExciPlex competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ExciPlex financial estimates
Financial estimateRevenue estimate
Valuation estimate
ExciPlex leadership team
Management profileNumber of profiles
Profiles2 records
ExciPlex funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ExciPlex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ExciPlex
What does ExciPlex do?
ExciPlex invents diagnostic assays, builds detection systems, and supplies critical reference materials for agricultural and environmental monitoring of natural toxins. The company manufactures high-purity purified toxins (mycotoxins, cyanotoxins, plant-derived toxins, ergot alkaloids), proprietary assay components (extraction buffers, assay buffers, culture media), and a portable dual-mode spectrophotometer/fluorimeter with cloud-connected quantification software. It complements these products with assay development, synthetic chemistry, and consulting services.
Is ExciPlex a public or private company?
ExciPlex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ExciPlex founded?
ExciPlex was founded in 2020. It employs 1 to 10 people.
Where is ExciPlex based?
ExciPlex is headquartered in Ann Arbor, United States, in the North America region.
How does ExciPlex make money?
Six revenue lines are on record. Toxin and Specialty Chemical Products are the primary driver. The others are assay Development Services, synthetic Chemistry Services, consulting Services, portable Detection Devices and technology Licensing and Partnership.
Does ExciPlex have an API?
No public API is recorded for ExciPlex.
What industry is ExciPlex in?
ExciPlex's product category is Toxin Detection Diagnostics. Its primary akta.pro industry code is AFALAFAC, Mycotoxin Testing (Aflatoxins, Ochratoxin, DON, ZEN, Fumonisins), with a secondary code of AFALAAAF, Residue & Contaminant Testing (Pesticides, Vet Drugs, Mycotoxins, Heavy Metals). Its NAICS code is 334516 and its SIC code is 8734.